Evidence map›Paper›PMID 41315587›Full record

ArticleScientific reports2025

Epigallocatechin-3-gallate ameliorates lipopolysaccharide-induced inflammation via the 67LR/JAK2/STAT3 signaling pathway.

Shiming Fan, Xiaoqing Fan, Ning Ma, Guofang Yin, Chunmei Zhang, Yuling Liang, Ying Luo, Yi Deng, Jing Zuo, Jingli Tang and 2 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Shiming Fan *Department of Respiratory and Critical Care Medicine, The Affiliated Hospital, Southwest Medical University, Luzhou, 646000, Sichuan, China.
Xiaoqing Fan *Department of Respiratory and Critical Care Medicine, The Affiliated Hospital, Southwest Medical University, Luzhou, 646000, Sichuan, China.
Ning MaDepartment of Respiratory and Critical Care Medicine, The Affiliated Hospital, Southwest Medical University, Luzhou, 646000, Sichuan, China.
Guofang YinDepartment of Respiratory and Critical Care Medicine, The Affiliated Hospital, Southwest Medical University, Luzhou, 646000, Sichuan, China.
Chunmei ZhangDepartment of Respiratory and Critical Care Medicine, The People's Hospital of Jiang'an County, Yibin, 644200, Sichuan, China.
Yuling LiangDepartment of Respiratory and Critical Care Medicine, The Affiliated Hospital, Southwest Medical University, Luzhou, 646000, Sichuan, China.
Ying LuoDepartment of Respiratory and Critical Care Medicine, Jiang'an Hospital of Traditional Chinese Medicine, Yibin, 644200, Sichuan, China.
Yi DengDepartment of Respiratory and Critical Care Medicine, The People's Hospital of Jiang'an County, Yibin, 644200, Sichuan, China.
Jing ZuoDepartment of Respiratory and Critical Care Medicine, Jiang'an Hospital of Traditional Chinese Medicine, Yibin, 644200, Sichuan, China.
Jingli TangDepartment of Pediatrics, The People's Hospital of Jiang'an County, Yibin, 644200, Sichuan, China.
Dan LuoDepartment of Respiratory and Critical Care Medicine, The Affiliated Hospital, Southwest Medical University, Luzhou, 646000, Sichuan, China. luodanwy1112@163.com.
Xianming FanDepartment of Respiratory and Critical Care Medicine, The Affiliated Hospital, Southwest Medical University, Luzhou, 646000, Sichuan, China. fxm129@swmu.edu.cn.

Funding

Jiang'an County Bureau of Economic Commerce, Informatization, and Science and Technology 2023SF01Luzhou Science and Technology program 2023JYJ049Natural Science Foundation of Sichuan Province 2022NSFSC0046School-level Scientific Research project of Southwestern Medical University 2023ZD007Sichuan Science and Technology program 2022YFS0631Yibin Science and Technology program 2023SF002
6 · The paper itself

Abstract

Lipopolysaccharide (LPS) can trigger an inflammatory response in lung epithelial cells, which may contribute to the development of Acute Respiratory Distress Syndrome (ARDS). Epigallocatechin-3- gallate (EGCG), a bioactive constituent in green tea, is widely acknowledged for its anti-inflammatory characteristics. This study explored the anti-inflammatory effects of EGCG and its potential molecular mechanisms in mouse lung epithelial-12 (MLE-12) cells. MLE-12 cells were pre-exposed to increasing EGCG concentrations (5, 7.5, and 10 µM) for 24 h, followed by exposure to LPS (20 ng/mL) to induce inflammation After induction, cell and supernatant samples were collected. A range of detection methods were applied to systematically assess the anti-inflammatory activities and the latent mechanisms of EGCG, comprising real-time polymerase chain reaction assay (RT-PCR), enzyme-linked immunosorbent assays (ELISA), western blotting, the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP), transcriptome sequencing, immunofluorescence, co-immunoprecipitation, and confocal microscopy imaging. EGCG exhibited anti-inflammatory effects in LPS-stimulated MLE-12 cells by inhibiting the pro-inflammatory cytokines IL-1β, IL-6, and TNF-α. Its primary mechanism involves robust attachment to 67-kDa laminin receptor (67LR), which modulates the interaction between 67LR and the JAK2 protein within the JAK2/STAT3 signaling pathway. This results in a considerable diminishment in LPS-induced production and expression of inflammatory-promoting cytokines in MLE-12 cells. EGCG attenuates the inflammatory reaction in MLE-12 cells by binding to 67LR and inhibiting the JAK2/STAT3 signaling pathway. The current study explored the effects of EGCG on LPS-induced inflammation in MLE-12 cells, which may offer some new perspectives in inflammation research and broadening our comprehension of the fundamental mechanisms inflammation-related diseases. Considering EGCG's role in suppressing inflammation in MLE-12 cells, it is reasonable to advocate, from a preventive perspective, the inclusion of EGCG-rich foods as a dietary component for helping alleviate the probability of inflammation-associated disorders.

Indexed as

Anti-Inflammatory AgentsCatechinInflammationJanus Kinase 2LipopolysaccharidesSignal TransductionSTAT3 Transcription FactorAnimalsCell LineMiceAnti-Inflammatory AgentsCatechinepigallocatechin gallateJak2 protein, mouseJanus Kinase 2LipopolysaccharidesStat3 protein, mouseSTAT3 Transcription Factor67-kDa laminin receptorAcute respiratory distress syndromeEpigallocatechin-3-gallateInflammatoryJAK2/STAT3 signaling pathway

Identifiers

PMID41315587
PMCPMC12663102

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.